The U.S. Food and Drug Administration approves first biologic for treatment of eczema

13/04/2017

On March 28th 2017, the US Food and Drug Administration (FDA) approved a new drug called dupilumab (brand name: Dupixent) for the treatment of adults with moderate-to-severe atopic dermatitis (also known as atopic eczema) that is not adequately controlled with topical treatment, or for whom topical treatments are not appropriate This new drug is administered by injection under the skin and can...

Read more

Exciting line up announced for ISF Dermatology Study Day 2017

22/03/2017

The ISF is delighted to announce details of its 2nd annual Dermatology Study Day which takes place 13th May 2017 in the Ashling Hotel, Dublin Guests of the ISF Study Day can look forward to an incredible line up of expert speakers from the world of dermatology The informative training for hospital, community-based, GP practice and public health nurses, pharmacists and others involved in...

Read more

Selene Daly speaks with Pat Kenny about Rosacea

07/03/2017

Listen back to Dermatology Clinical Nurse Specialist Selene Daly speaking with Pat Kenny on the subject of Rosacea, 'The Curse of the Celts' For more information on Rosacea, please consult the ISF's Information Booklet on the condition If you are experiencing difficulty managing acne or any other skin condition, ask an ISF dermatology clinical nurse specialist for...

Read more

People living with HS speak out about misunderstood and misdiagnosed condition

06/03/2017

#Five17Eight campaign highlights frequently delayed diagnosis of common chronic skin disease  The ISF is encouraging those potentially living with the chronic skin condition hidradenitis suppurativa (HS) to reach out and seek information about their condition As a part of this campaign, entitled #Five17Eight, we have launched an online hub dedicated to HS From symptom recognition to care...

Read more

HS Community Meetings in Dublin & Cork announced for April

28/02/2017

The ISF will host two free HS Community Meetings in Dublin and Cork during April for anyone affected by Hidradenitis Suppurativa At each meeting a consultant dermatologist will talk about the condition, followed by an optional closed/private session, lead by the HS Facebook Support Group's Barry McGrath, to provide a confidential forum for discussion and an opportunity to meet other people...

Read more

Role of the skin barrier in atopic dermatitis: Prof. Alan Irvine

23/02/2017

Role of the skin barrier in atopic dermatitis Atopic deramatitis and other types of eczema are very common, especially in young children, and the dry, itchy and damaged skin can be difficult to manage Prof Irvine, of Our Lady’s Children’s Hospital, Crumlin and Trinity College Dublin, shared his insights and experience about atopic dermatitis He explained how it hampers the skin’s...

Read more

A parent’s experience of eczema

14/02/2017

Parent and former Board Member of the ISF Jeannette Brazel discusses her personal eczema journey and how treatment of the condition has changed in the past 14 years  Jeannette pictured above, second from the right with some of the ISF team and volunteers at Barrettstown in 2015 My son is now 14 From the moment he was born he was scratching  At his 6-week check up he was covered with a...

Read more

New treatments for eczema and atopic dermatitis may be on the way

22/12/2016

On 14 December, the US Food and Drug Administration approved the first non-steroidal therapy for eczema in more than 15 years The drug, an ointment called Eucrisa (crisaborole), inhibits a protein called phosphodiesterase-4 and was developed by Anacor Pharmaceuticals of Palo Alto, California (a company recently acquired by Pfizer) It targets an anti-inflammatory mechanism already used in drugs...

Read more

Mindfulness & Psoriasis Research Study

20/12/2016

The Department of Dermatology in St Vincent’s University Hospital are conducting new research with people who have psoriasis using a technique called Mindfulness If you choose to take part in this research you will be randomly assigned to one of two possible treatment groups: 1 Mindfulness Based Cognitive Therapy or 2 Treatment as Usual What is involved in the Mindfulness Group (MBCT) 8...

Read more

New national pilot scheme to fast track treatment for babies with complicated ‘strawberry birthmarks’.

19/12/2016

New national pilot scheme to fast track treatment for babies with complicated ‘strawberry birthmarks’ Doctors at Cork University Hospital have devised a new photo-triage system for babies with infantile haemangiomas (also known as strawberry birthmarks) What are infantile haemangiomas An ‘infantile haemangioma’ is a type of vascular birthmark, which consists of a soft, raised...

Read more

No safe limit for exposure to ultraviolet radiation from sunbeds

16/12/2016

No safe limit for exposure to ultraviolet radiation from sunbeds It's official, there is no safe limit for exposure to ultraviolet radiation (UV) from sunbeds, according to independent scientific committee Skin cancer is the most common cancer in Ireland, with rates projected to treble in the next 25 years Yet, in most cases, it is also one of the most preventable forms of cancer There are...

Read more